Sudarshan Pharma Industries

29.53
-0.60
(-1.99%)
Market Cap
710.70 Cr
EPS
4.76
PE Ratio
61.52
Dividend Yield
0.10 %
Industry
0.00
52 Week High
53.50
52 Week Low
5.82
PB Ratio
6.36
Debt to Equity
0.65
Sector
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
0.80 %
Net Income Growth
64.29 %
Cash Flow Change
120.88 %
ROE
47.06 %
ROCE
51.26 %
EBITDA Margin (Avg.)
59.36 %

Yearly Financial Results

Annual Financials
2021
2022
2023
2024
TTM
Revenue
194
358
462
466
0
Expenses
186
346
447
441
0
EBITDA
8
11
16
25
0
Operating Profit %
4 %
3 %
3 %
5 %
0 %
Depreciation
1
1
1
1
0
Interest
3
3
5
9
0
Profit Before Tax
4
7
10
15
0
Tax
1
2
3
4
0
Net Profit
3
5
7
12
0
EPS in ₹
2.74
5.46
5.48
4.76
0.00

Balance Sheet

Balance Sheet
2021
2022
2023
2024
Total Assets
99
138
233
283
Fixed Assets
6
7
20
26
Current Assets
88
130
199
242
Capital Work in Progress
0
1
0
2
Investments
0
0
0
2
Other Assets
93
131
213
254
Total Liabilities
99
138
233
283
Current Liabilities
71
103
119
161
Non Current Liabilities
6
5
13
11
Total Equity
23
30
101
112
Reserve & Surplus
13
20
77
88
Share Capital
10
10
24
24

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
Net Cash Flow
-2
0
-1
12
-12
Investing Activities
-3
-1
-2
-26
-6
Operating Activities
1
3
-4
-29
6
Financing Activities
-0
-2
4
66
-12

Share Holding

% Holding
Mar 2023
Sept 2023
Mar 2024
Sept 2024
Promoter
57.39 %
57.39 %
57.39 %
57.39 %
FIIs
0.00 %
1.40 %
1.40 %
13.07 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
20.35 %
27.04 %
23.61 %
23.20 %
Others
22.26 %
14.16 %
17.59 %
6.33 %
No of Share Holders
2,785
983
913
787

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.3 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.05 0.00 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Updates on AcquisitionApr 03, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionApr 03, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateApr 01, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateApr 01, 2025
Closure of Trading WindowMar 31, 2025
Change In Market Maker Of The CompanyMar 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 20, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMar 06, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Mar 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 04, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionFeb 26, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionFeb 26, 2025
Announcement under Regulation 30 (LODR)-AcquisitionFeb 19, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 07, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 05, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMFeb 05, 2025
Proceedings Of Extraordinary General MeetingFeb 04, 2025
Corrigendum To Notice Of Extra-Ordinary General Meeting Dated 10-Jan-2025Jan 31, 2025
Announcement under Regulation 30 (LODR)-Issue of SecuritiesJan 31, 2025
Technology Transfer Agreement With Uttaranchal UniversityJan 25, 2025
Announcement under Regulation 30 (LODR)-AcquisitionJan 16, 2025
Premises Taken On Rent For Setting Up New Research & Development Formulation Centre In Dehradun Uttarakhand India - ClarificationJan 16, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 14, 2025
Extraordinary General Meeting On Tuesday February 4 2025Jan 13, 2025
Board Meeting Outcome for Preferential Issue Of WarrantsJan 10, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 09, 2025
Premises Taken On Rent For Setting Up New Research & Development Formulation Centre In Dehradun Uttarakhand IndiaJan 07, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday January 10 2025Jan 06, 2025
Announcement under Regulation 30 (LODR)-AcquisitionNov 29, 2024
Announcement under Regulation 30 (LODR)-CessationNov 29, 2024
Shareholder Meeting / Postal Ballot-Scrutinizers ReportNov 21, 2024
Shareholder Meeting / Postal Ballot-Outcome of EGMNov 21, 2024
Addendum To The Notice Of The Extraordinary General Meeting Of Sudarshan Pharma Industries Limited Held On Monday, 30Th September, 2024Nov 18, 2024
Revised Record Date I.E. November 23, 2024 For The Purpose Of Sub-Division/ Split Of Shares Of The CompanyNov 08, 2024
Fixation Of November 18, 2024 As Record Date For The Purpose Of Sub-Division/Split Of Face Value Of Equity Shares Of The Company.Nov 07, 2024
Shareholder Meeting / Postal Ballot-Scrutinizers ReportNov 05, 2024
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotNov 05, 2024
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotNov 05, 2024
Financial Results For The Half Year Ended 30Th September 2024Oct 31, 2024
Board Meeting Intimation for Board Meeting On 31/10/2024Oct 25, 2024
Announcement under Regulation 30 (LODR)-AcquisitionOct 14, 2024
Shareholder Meeting / Postal Ballot-Notice of Postal BallotOct 04, 2024
Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2024
Shareholder Meeting / Postal Ballot-Outcome of EGMOct 01, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportOct 01, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMOct 01, 2024
Shareholder Meeting / Postal Ballot-Outcome of EGMSep 30, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2024
Corporate Action-Outcome of Sub division / Stock SplitSep 30, 2024
Board Meeting Intimation for Board Meeting On 30-09-2024Sep 24, 2024

Technical Indicators

RSI(14)
Neutral
39.80
ATR(14)
Less Volatile
1.33
STOCH(9,6)
Neutral
33.27
STOCH RSI(14)
Neutral
40.48
MACD(12,26)
Bullish
0.17
ADX(14)
Strong Trend
29.42
UO(9)
Bearish
51.85
ROC(12)
Downtrend And Accelerating
-2.99
WillR(14)
Neutral
-79.40